Biologics
Page 1 • 2 itemsGlobal biologics market intelligence: Discover regulatory updates, R&D trends, and investment opportunities in biopharmaceuticals.
WuXi Biologics Chengdu Microbial Manufacturing Site Reaches Structural Completion, Targets 2026 GMP Production
WuXi Biologics announces structural completion of its Chengdu microbial manufacturing facility with key equipment arrival, targeting GMP production by end 2026.
Australia's TGA Updates Comprehensive Biologicals Regulatory Framework for Advanced Therapies
Australia's TGA provides updated guidance on biologicals regulation including blood products, tissues, and advanced therapies under ARGB framework.